WNBA Commissioner Cathy Engelbert publicly addressed the leagues position on transgender athlete participation during a recent media availability, confirming that discussions about inclusion policies remain ongoing. Her comments come amid heightened public interest sparked by former NBA players, including Enes Kanter, declaring eligibility for the 2027 WNBA Draft, which has intensified scrutiny on the leagues current rules regarding athlete eligibility.
The WNBA's current policy, aligned with FIBA and IOC guidelines, permits transgender women to compete if they maintain testosterone levels below a specified threshold for at least 12 months prior to competition. Engelbert reiterated that the league continues to review its policies in consultation with medical experts, athletes, and advocacy groups to ensure fairness and inclusivity, noting that any changes would require collective bargaining agreement approval.
We are committed to fostering an environment where all athletes feel welcome and respected, while also protecting the integrity of competition, Engelbert stated. Our approach is grounded in science, medical guidance, and ongoing dialogue with stakeholders across the basketball ecosystem.
Analysts note that the intersection of transgender participation policies and draft eligibility rules presents a novel challenge for the WNBA. While no former NBA player has yet met the league's current criteria for draft eligibility, the declarations have prompted league officials to clarify existing rules and consider potential future adjustments to maintain competitive balance.
The WNBPA has publicly supported inclusive policies, emphasizing that the unions priority is ensuring all athletes can compete safely and without discrimination. Engelbert acknowledged the unions stance, stating that the league values its partnership with the players' association in shaping policies that reflect both inclusivity and competitive fairness.
Looking ahead, the WNBA expects to continue its policy review process through 2025, with any potential changes unlikely to take effect before the 2026 season at the earliest. The league plans to engage further with medical consultants and international basketball federations to ensure its policies remain consistent with global standards while addressing evolving societal expectations.
WNBA Commissioner Cathy Engelbert on Inclusion and Competition
The league's ongoing evaluation reflects broader trends in professional sports, where governing bodies are increasingly tasked with balancing inclusion initiatives against competitive equity concerns. Engelbert emphasized that the WNBA's approach will remain transparent and evidence-based, avoiding reactive decisions in favor of deliberate, stakeholder-informed policy development.
As the 2027 draft cycle approaches, the WNBA anticipates continued attention on its eligibility rules, particularly as more athletes from diverse backgrounds explore professional opportunities in women's basketball. Engelbert concluded by reaffirming the leagues dedication to growing the sport responsibly, stating that inclusivity and competitive integrity are not mutually exclusive goals but complementary pillars of the WNBAs future.
Key questions
- What is the WNBA's current policy on transgender athlete participation?
- The WNBA follows FIBA and IOC guidelines, allowing transgender women to compete if they maintain testosterone levels below 5 nmol/L for at least 12 months prior to competition. The policy requires medical verification and is subject to ongoing review in consultation with experts and stakeholders.
- Can former NBA players like Enes Kanter declare for the WNBA Draft?
- Former NBA players can declare for the WNBA Draft only if they meet the league's current eligibility criteria, including transgender participation policies if applicable. As of now, no former NBA player has satisfied the WNBA's requirements for draft eligibility, though declarations have prompted league officials to clarify existing rules.
